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The Role of Radiation Therapy in Renal Carcinoma
Joel Elliot White, MD*

In the treatment of renal adenocarcinoma, radiation therapy
alone is insufficient. Preoperative radiation increases the
resectability rate and delays metastasis, but overa// improvement in survival is tentative. Postoperative radiation has not
been of proven benefit. While palliation may be achieved,
relatively high doses of radiation are required.

The relative radioresistance of renal adenocarcinoma
compared to the sensitivity of the surrounding normal
tissues makes definitive radiation alone inappropriate for
curative therapy. As an adjuvant to definitive surgery,
radiation remains controversial, although some randomized
clinical trials are presently active. While palliation may be
achieved, relatively high doses of radiation are necessary

Preoperative Radiation
As early as 1935, reports'''^ in the literature indicated that
preoperative radiation c o u l d convert renal adenocarcinomas from nonresectable to resectable. In addftion to
conversion, some theoretical advantages to preoperative
radiation include:
a) Reduction in viability of tumor cells, thereby reducing
the incidence of distant metastasis caused by the
release of cells during surgical manipulation.
b) Reduction of microscopic peripheral extensions into
pericapsular and perirenal tissue, thereby reducingthe
risk of transecting viable tumor.
c) Reduction in the incidence of local recurrence by
directly affecting surrounding normal tissues to make
them less susceptible to implantation.
d) Sterilization of microdeposits in lymph nodes.
Several reported series ^'^ have indicated no survival advantage with preoperative radiation.
Werf-Messing^ reported the first large, randomized series
from the Netherlands. Although there was no survival
advantage, she observed that the unresectability rate decreased from 38% to 20% for patients with pericapsular
extension and preoperative irradiation. When venous or
lymphatic invasion occurred, 78% of patients could be
completely resected ifthey had received preoperative radiation, but only 48% could be resected if this treatment had
not been given. Further, itwas noted that metastases did not
develop as rapidly in patients whose tumor was completely
resected.
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Inthe United States, a national renal cell cooperative trial is
in progress. A higher dose of radiation was chosen with
complex techniques of administration being employed to
limit the dose to vital structures. Preliminary analysis of the
data by Rubin et al^ indicated no advantage to patients with
stage I disease. In the preoperatively irradiated group,
patientswith stage II disease showed a 15-20% improvement in two-year survival. As in the Netherlands' study,
patients who had complete tumor resection took longer to
manifest distant metastasis. Also, a much higher percentage
of patients with preoperative radiation were completely
resected. A major problem Rubin, et al* noted was the
extreme difficulty in delivering the required tumor dose to
the lymph node-bearing region. Therefore, they recommended surgical resection of regional nodes and venous
tumor thrombus, if present, because it was impossible to
radiate these areas without exceeding normal tissue tolerance. More patients and longer follow-up are necessary.

the postoperative radiation group was due to radiation
complications, primarily to radiation hepatitis in right-sided
lesions. He also found no difference in the incidence of
local recurrence of distant metastasis. Of prime importance
were known prognostic factors such as renal vein invasion
and capsular extension.

Palliative Radiation
The relief of symptoms dueto local tumor mass or metastasis
can be achieved in a large proportion of patients. Our
experience is similar to that reported by Vaeth''" in that
relatively high doses in the range of 4-5,000 rads in four to
five weeks are necessary. In the palliative category are such
problems as bone pain, brain metastasis, and bronchial
obstruction. We have also treated two patients with tumor
thrombus extending up the inferior vena cava into the right
atrium of the heart. While we did not note any significant
i m p r o v e m e n t , Malkin,^* in a similar case, docmented
marked regression which made the patient resectable.

Postoperative Radiation
In 1951, Riches, et
reported on a series of 1,746 cases
studied by the British Association of Urologic Surgeons.
Flocks and Kadesky^ and Riches'" suggested the following
indications for postoperative radiation: perinephric tumor
invasion, incomplete resection, and regional lymph node
metastasis. On an individual basis, surgical spillage of
tumor into the renal bed has also been considered as an
indication.

Summary
Both pre- and postoperative radiation are local measures in
renal adenocarcinoma. Preoperative radiation increases
the resectability rate and delays metastasis. However, any
overall improvement in survival is tentative with more study
needed. Postoperative radiation has not been of demonstrated benefit. Improvement in controlling distant spread is
required before any additional benefft from radiation used
for local control can be demonstrated. High doses of
radiation are required to gain maximum benefft both as a
surgical adjuvant and for palliation.

While the former studies suggest a 10-15% improvement in
five-year survival, randomized clinical trials reported by
Peeling et a l " and Finney'^ indicated no significant difference, or even a slightly worse result, with postoperative
radiation. Finney^^ suggested that the lessened survival in
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